Whippany, New Jersey, United States
NCT Number: NCT02527278
Retrospective Claims Analysis of Hysterectomy After Sterilization
The research questions are:
1. What is the proportion of women undergoing hysterectomy after hysteroscopic sterilization or laparoscopic tubal ligation? 2. What is the proportion of women undergoing salpingectomy, salpingostomy, or hysteroscopy after hysteroscopic sterilization or laparoscopic tubal ligation? 3. What is the proportion of women who have a diagnosis of pelvic pain after hysteroscopic sterilization or laparoscopic tubal ligation?
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–49 year
Sex eligibility
Female
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Women aged 18 through 49 years at the index date
- at least one claim of the hysteroscopic sterilization procedure or interval laparoscopic tubal ligation at any time during January 1, 2010 -December 31, 2012
- Had 6 months of continuous medical and pharmacy benefits pre-index date which is considered the baseline period to capture all patient characteristics prior to the procedure
- Had 12 months of continuous medical and pharmacy benefits post-index date (i.e., follow-up period)
Exclusion criteria
- Women who underwent a postpartum tubal ligation procedure during the entire study period
- Women who had claims of a sterilization procedure during the baseline period
- Women who had a claim for pregnancy or delivery within 6 weeks prior to the index date
- Women who had more than one type of sterilization procedure (i.e., combination of hysteroscopic sterilization, laparoscopic tubal ligation or mini-laparotomy) on the same index date
- Women who had concurrent procedures on the same day as the index sterilization procedure that were performed for reasons beyond the purpose of sterilization
Treatment and study plan
Laparoscopic tubal ligation
ProcedureFemale permanent birth control method performed via a surgical procedure
Hysteroscopic sterilization
ProcedureFemale permanent birth control method performed via placement of a device
Primary outcomes
-
Proportion of women undergoing hysterectomy after hysteroscopic sterilization or laparoscopic tubal ligation
Time frame: Within 12 months after the procedure
Secondary outcomes
-
Proportion of women undergoing salpingectomy after hysteroscopic sterilization or laparoscopic tubal ligation
Time frame: Within 12 months after the procedure
-
Proportion of women undergoing salpingostomy after hysteroscopic sterilization or laparoscopic tubal ligation
Time frame: Within 12 months after the procedure
-
Proportion of women undergoing hysteroscopy after hysteroscopic sterilization or laparoscopic tubal ligation
Time frame: Within 12 months after the procedure
-
Proportion of women who have a diagnosis of pelvic pain after hysteroscopic sterilization or laparoscopic tubal ligation
Time frame: Within 12 months after the procedure
Sponsors and collaborators
Lead sponsor
Bayer
Industry
Registry information
Official study title
A Retrospective Claims Analysis to Calculate the Proportion of Women Undergoing Hysterectomy, Salpingectomy, Salpingostomy, Hysteroscopy or Who Had a Diagnosis of Pelvic Pain After Hysteroscopic Sterilization or Laparoscopic Tubal Ligation
Important dates
- Study start
- 2015
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Aug 18, 2015
- Registry last updated
- Mar 21, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A 3-way Crossover Clinical Investigation to Assess the Performance of Two Different Sized Polyurethane Condoms Versus a Latex Condom in Healthy Monogamous Couples.
NCT06557499
Contraception
Berkeley, California, United States
View Trial DetailsVerbal Analgesia During Copper IUD Insertion After Cesarean Delivery
NCT07326007
Contraception
Giza, Egypt
View Trial DetailsPostpartum Integration of Vaccines and Contraception Trial
NCT05732142
Contraception, Gender Equity
La Jolla, California, United States
View Trial DetailsStudy to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization
NCT03127722
Contraception
Chandler, Arizona, United States
View Trial Details